Guidance Archives - Page 76 of 637

2 minute read

Analysts Raises Forecasts On UnitedHealth On Controlled Growth Strategy After Cyber Hack

April 17, 3:54 PM

UnitedHealth reports robust Q1 results despite cybersecurity challenges. Revenue exceeds $99.8 billion, with adjusted EPS of $6.91, surpassing expectations. Analysts upbeat, Piper Sandler raises price target to $571, while Truist maintains Buy with $600 target.

UNH

1 minute read

Why Knight-Swift Transportation Shares Are Falling Today

By Shivani Kumaresan

April 17, 1:06 PM

Investor sentiment wanes as Knight-Swift revises its first and second-quarter earnings guidance downwards. The updated outlook cites challenges in the full truckload industry, exacerbated by weather disruptions and pricing headwinds.

KNX

2 minute read

Why Prologis Shares Are Trading Lower Today

By Lekha Gupta

April 17, 9:26 AM

Prologis shares down after reporting Q1 results, with lower rental revenue and reduced FY24 guidance due to market conditions. CEO remains positive about long-term growth.

FPRO

3 minute read

Royal Gold Provides 2024 Guidance; Sees Total Sales Of Gold 215,000–230,000 Oz, Silver 3.2M–3.8M Oz, Copper 14M–16M Lb, Other Metals $17M–$20M, DD&A $141M–157M, Effective Tax Rate 17%–22%

By Benzinga Newsdesk

April 17, 9:17 AM

Royal Gold, Inc. (NASDAQ:RGLD) (together with its subsidiaries, "Royal Gold" or the "Company," "we" or "our") announced today its guidance for calendar year 2024 total stream and royalty sales volume, depletion,

RGLD

3 minute read

Cannabis Brands Leading Market Expansion In East & Midwest: A Look At Prices And Trends

By Nicolas Jose Rodriguez

April 17, 8:50 AM

In a recent sector analysis by Pablo Zuanic of Zuanic & Associates, key trends across four Eastern states are dissected to understand the brand landscape of the cannabis market.

AAWH

2 minute read

Why U.S. Bancorp Shares Are Diving Premarket Today

By Lekha Gupta

April 17, 8:46 AM

U.S. Bancorp reported a decline in revenue and net interest income for Q1 2024, but beat adjusted earnings expectations. FY24 guidance was also lowered.

FTXO

1 minute read

Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance

By Vandana Singh

April 17, 8:42 AM

Abbott Laboratories surpasses expectations with Q1 sales hitting $9.96B, a 10.8% rise driven by robust performance in Medical Devices, Established Pharmaceuticals, Nutrition, and Diagnostics. CEO Robert Ford boosts full-year sales outlook amidst strong Q1 growth.

ABT

3 minute read

Oxford Lane Capital Corp. Preliminary Q4 Core Net Investment Income $0.32-$0.38; Cash And Cash Equivalents ~$43M

By Benzinga Newsdesk

April 17, 8:21 AM

Oxford Lane Capital Corp. (NASDAQ:OXLC) (NASDAQ:OXLCM) (NASDAQ:OXLCP) (NASDAQ:OXLCL) (NASDAQ:OXLCO) (NASDAQ:OXLCZ) (NASDAQ:OXLCN) (the "Company," "we," "us" or "our") today announced preliminary estimates and financial

OXLC

2 minute read

What’s Going On With VinFast Shares After Reaffirming Outlook Of 100,000 EV Deliveries?

By Nabaparna Bhattacharya

April 17, 8:17 AM

VinFast shares rise after reporting Q1 earnings, with 100,000 EV delivery target for FY24 reaffirmed amidst global expansion plans.

VFS

1 minute read

Prologis Revises FY24 Core FFO From $5.50-$5.64 To $5.45-$5.55

By Benzinga Newsdesk

April 17, 8:09 AM

2024 GUIDANCEEarnings (per diluted share) PreviousRevisedChange at M.P. Net earnings attributable to common stockholders$3.20 to $3.45$3.15 to $3.35(2.3) %Core FFO attributable to common

PLD